|
Volume
15 Number 1
31 January 2015
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
17, Year 2015 >
Number 1, 31 January
|
|
|
|
|
|
Mallidi
S, Watanabe K, Timerman D, Schoenfeld D, Hasan T.
Prediction
of tumor recurrence and therapy monitoring using ultrasound-guided
photoacoustic imaging.
Theranostics.
2015 Jan 1;5(3):289-301. doi: 10.7150/thno.10155🡥.
PMID: 25553116🡥.
Laboratory investigation. ˍ
|
|
|
|
Jia
PF, Gu WT, Zhang WF, Li F.
Treatment
of recurrent malignant gliomas with 13-cis-retinoic acid
naphthalene triazole.
Neurol
Sci.
2015 Jan 6, 2015;36(5):717-21. doi: 10.1007/s10072-014-2025-9🡥.
PMID: 25560534🡥.
Clinical trial. ˍ
|
|
|
|
Chamberlain
MC.
Salvage
therapy with lomustine for temozolomide refractory recurrent
anaplastic astrocytoma: a retrospective study.
J
Neurooncol.
2015 Jan 7, 2015;122(2):329-38. doi:
10.1007/s11060-014-1714-9🡥.
PMID:
25563816🡥.
Retrospective
analysis. ˍ
|
|
|
|
Lee
EQ, Reardon DA, Schiff D, Drappatz J, Muzikansky A, Grimm SA,
Norden AD, Nayak L, Beroukhim R, Rinne ML, Chi AS, Batchelor TT,
Hempfling K, McCluskey C, Smith KH, Gaffey SC, Wrigley B, Ligon
KL, Raizer JJ, Wen PY.
Phase
II study of panobinostat in combination with bevacizumab for
recurrent glioblastoma and anaplastic glioma.
Neuro
Oncol.
2015 Jan 7, 2015;17(6):862-7. doi: 10.1093/neuonc/nou350🡥.
PMID: 25572329🡥.
Phase 2 trial. ˍ
Neuro
Oncol.
2015 Sep 19. 2015;17(12):1650. doi: 10.1093/neuonc/nov201🡥.
PMID: 26386410🡥.
Correction. ˍ
|
|
|
|
Duerinck
J, Clement PM, Bouttens F, Andre C, Neyns B, Staelens Y, Van
Fraeyenhove F, Baurain JF, Luce S, D'hondt L, Joosens E, Specenier
P, Verschaeve V, Filleul B, Vroman P, Stragier B, Rogiers A.
Patient
outcome in the Belgian medical need program on bevacizumab for
recurrent glioblastoma.
J
Neurol.
2015 Jan 9, 2015;262(3):742-51. doi: 10.1007/s00415-014-7633-z🡥.
PMID: 25572162🡥.
Clinical trial. ˍ
|
|
|
|
Hacibekiroglu
I, Kodaz H, Erdogan B, Turkmen E, Ozcelik M, Esenkaya A, Saygi HM,
Uzunoglu S, Cicin I.
Single-agent
bevacizumab is an effective treatment in recurrent
glioblastoma.
Med
Oncol.
2015 Jan 9, 2015;32(2):460. doi: 10.1007/s12032-014-0460-3🡥.
PMID: 25572814🡥.
Retrospective analysis. ˍ
Med
Oncol.
2015 Mar 19. 2015;32(4):119. doi: 10.1007/s12032-015-0482-5🡥.
PMID: 25782869🡥.
Correction. ˍ
|
|
|
|
Levin
VA, Mendelssohn ND, Chan J, Stovall MC, Peak SJ, Yee JL, Hui RL,
Chen DM.
Impact
of bevacizumab administered dose on overall survival of patients
with progressive glioblastoma.
J
Neurooncol.
2015 Jan 11, 2015;122(1):145-50. doi: 10.1007/s11060-014-1693-x🡥.
PMID: 25575937🡥.
Retrospective analysis. ˍ
|
|
|
|
Yordanova
YN, Rodriguez-Arribas MA, Duffau H.
Long-term
stabilization by radiosurgery of a secondary focal anaplastic
transformation in a surgically treated WHO grade II
oligodendroglioma. A case report.
Neurochirurgie.
2015 Jan 13, 2015;61(1):46-9. doi: 10.1016/j.neuchi.2014.11.006🡥.
PMID: 25595594🡥. Case report. ˍ
|
|
|
|
Niranjan
A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.
Role
of adjuvant or salvage radiosurgery in the management of
unresected residual or progressive glioblastoma multiforme in the
pre-bevacizumab era.
J
Neurosurg.
2015 Jan 16, 2015;122(4):757-65. doi: 10.3171/2014.11.JNS13295🡥.
PMID: 25594327🡥.
Retrospective analysis. ˍ
|
|
|
|
Pitz
MW, Eisenhauer EA, MacNeil MV, Thiessen B, Easaw JC, Macdonald DR,
Eisenstat DD, Kakumanu AS, Salim M, Chalchal H, Squire J, Tsao MS,
Kamel-Reid S, Banerji S, Tu D, Powers J, Hausman DF, Mason WP.
Phase
II study of PX-866 in recurrent glioblastoma.
Neuro
Oncol.
2015 Jan 20, 2015;17(9):1270-4. doi: 10.1093/neuonc/nou365🡥.
PMID: 25605819🡥.
Phase 2 trial. ˍ
|
|
|
|
Wong
ET, Lok E, Swanson KD.
Clinical
benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and
TCCC after temozolomide and bevacizumab failure: a preliminary
observation.
Cancer
Med. 2015 Jan 26, 2015;4(3):383-91. doi: 10.1002/cam4.421🡥.
PMID: 25620708🡥.
Retrospective analysis. ˍ
|
|
|
|
Chen
W, Wang D, Du X, He Y, Chen S, Shao Q, Ma C, Huang B, Chen A, Zhao
P, Qu X, Li X.
Glioma
cells escaped from cytotoxicity of temozolomide and vincristine by
communicating with human astrocytes.
Med
Oncol. 2015 Jan 29, 2015;32(3):43🡥.
doi: 10.1007/s12032-015-0487-0🡥.
PMID: 25631631🡥.
Laboratory investigation. ˍ
Erratum
in: Med Oncol. 2021 Aug 24;38(10):117🡥.
Correction.
ˍ
|
|
|
|
|
|
|
|
|
